0
Your cart

Your cart is empty

Books > Medicine > Surgery

Buy Now

Comparative Effectiveness in Surgical Oncology - Key Questions and How to Answer Them (Hardcover, 2015 ed.) Loot Price: R3,351
Discovery Miles 33 510
You Save: R1,009 (23%)
Comparative Effectiveness in Surgical Oncology - Key Questions and How to Answer Them (Hardcover, 2015 ed.): Karl Y. Bilimoria,...

Comparative Effectiveness in Surgical Oncology - Key Questions and How to Answer Them (Hardcover, 2015 ed.)

Karl Y. Bilimoria, Christina A. Minami, David M. Mahvi

Series: Cancer Treatment and Research, 164

 (sign in to rate)
List price R4,360 Loot Price R3,351 Discovery Miles 33 510 | Repayment Terms: R314 pm x 12* You Save R1,009 (23%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Despite tremendous recent advances in the treatment of most malignancies, there remain several critical questions for each cancer. This particularly true for the surgical management of solid-organ malignancies. Comparative effectiveness is a relatively new term which encompasses the age-old concepts of how best to treat cancer patients. Comparative effectiveness is defined as the direct comparison of healthcare interventions to determine which work best for which patients when considering the benefits and risks. The Institute of Medicine has defined comparative effectiveness research(CER) as the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care. CER is certainly best done with well-conducted randomized controlled trials. Unfortunately, clinical trials are not always feasible owing to the impracticality of conducting the trial, the considerable cost, and the time required to complete the trial. These challenges are even more pronounced with respect to surgical treatment. Thus alternative approaches may need to be considered in order to address pressing questions in the care of the oncology patient. These approaches may include well-conducted retrospective cohort studies from cancer registries and other data sources, decision and cost-effectiveness analyses, and other novel methodologies. This book lays out the current critical questions for each major malignancy and proposes approaches to gain answers to these pressing questions.

General

Imprint: Springer International Publishing AG
Country of origin: Switzerland
Series: Cancer Treatment and Research, 164
Release date: March 2015
First published: 2015
Editors: Karl Y. Bilimoria • Christina A. Minami • David M. Mahvi
Dimensions: 235 x 155 x 18mm (L x W x T)
Format: Hardcover
Pages: 259
Edition: 2015 ed.
ISBN-13: 978-3-319-12552-7
Categories: Books > Medicine > Surgery > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-319-12552-4
Barcode: 9783319125527

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners